GlassScriptPhysician profile
Annie Cruz
NPI 1104086982
$2,847.68
in general payments reported to CMS, 2019-2025
39 companies · $304 in 2025
The $304 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $207 · 2020: $135 · 2021: $442 · 2022: $744 · 2023: $682 · 2024: $334 · 2025: $304.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,320.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,319.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $365.04 | 2019-2023 | Liletta |
| Mayne Pharma Commercial LLC | $280.70 | 2021-2025 | |
| Daiichi Sankyo INC. | $263.77 | 2019-2024 | Injectafer |
| Organon LLC | $192.33 | 2022-2025 | Nexplanon, Jada System |
| Astellas Pharma US INC | $181.73 | 2022-2024 | Veozah, Myrbetriq |
| Hologic Sales and Service, LLC | $167.68 | 2020-2025 | Acessa Provu System, Aptima |
| Coopersurgical, INC. | $137.15 | 2019-2024 | Paragard T 380a |
| Exeltis, USA INC. | $125.21 | 2021-2023 | Slynd |
| Myriad Women'S Health, INC. | $113.62 | 2023 | Myrisk |
| Biogen, INC. | $100.12 | 2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $92.59 | 2019-2023 | |
| Caldera Medical, INC | $74.41 | 2023 | Desara |
| Aspira Women'S Health INC | $72.00 | 2022 | |
| Pfizer INC. | $67.71 | 2023-2024 | |
| Sumitomo Pharma America, INC. | $59.87 | 2023-2025 | Myfembree |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optumhealth Care Solutions, LLC | $58.94 | 2023 | Vivify Health Care Team Portal, Zyno Solutions |
| Shield Therapeutics INC | $43.92 | 2023-2024 | Accrufer |
| Evofem Biosciences, INC. | $36.48 | 2021 | |
| Merck Sharp & Dohme LLC | $35.37 | 2019-2020 | |
| Monaghan Medical Corporation | $31.39 | 2024 | Aerochamber |
| Boston Scientific Corporation | $30.59 | 2019-2022 | |
| Novo Nordisk INC | $27.83 | 2021-2022 | |
| Mylan Pharmaceuticals INC. | $27.27 | 2019-2021 | |
| Amgen INC. | $23.38 | 2022 | |
| Northgate Technologies, INC. | $22.66 | 2024 | Stimsite |
| Dexcom, INC. | $22.40 | 2025 | Dexcom G6 Transmitter |
| Becton, Dickinson and Company | $19.77 | 2023 | Bd Onclarity |
| Vertical Pharmaceuticals, LLC | $19.76 | 2019 | |
| Radius Health, INC. | $17.03 | 2020 | |
| Ethicon US, LLC | $16.47 | 2025 | Harmonic |
| Medtronic, INC. | $15.21 | 2021 | |
| Avion Pharmaceuticals | $14.77 | 2021 | |
| Scynexis, INC. | $14.58 | 2022 | |
| Myovant Sciences INC. | $14.30 | 2021 | |
| Therapeuticsmd, INC. | $14.11 | 2020 | |
| Agile Therapeutics, INC. | $13.95 | 2022 | |
| Avanos Medical | $12.58 | 2019 | |
| Lupin INC. | $11.34 | 2019 | |
| Meditrina | $9.65 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Annie Cruz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.